Alopecia Areata in Persons of Color: Understanding Unmet Patient Needs and Treatment Strategies

To participate in this activity, please:

“It’s just hair loss,” doesn’t adequately describe the significant impact alopecia areata has on a patient’s appearance and self-esteem. The visible nature of the disease can lead to psychosocial effects such as stress, anxiety, depression, and social isolation. In this interactive, case-based activity, Brett King, MD, PhD, and Natasha Mesinkovska, MD, PhD, share their real-world experience treating patients with alopecia areata. They discuss the higher prevalence of alopecia areata in persons of color, psychological effects of the disease, diagnosis, and treatment approaches. Additionally, the efficacy, safety, and monitoring of JAK inhibitors are compared to other immunosuppressants, along with shared decision-making approaches, to provide patient-centered care.

Please visit our related course, Interprofessional Care of Patients with Alopecia Areata, by clicking here.

Course Credit:

1.00 AAPA Category I CME Credit
1.00 ACPE Contact Hour
1.00 AMA PRA Category 1 CreditTM
1.00 ANCC Contact Hour
1.00 CA-BRN Contact Hour
0.08 Pharmacology Hours

Dates:

Opens: 2025-03-27
Closes: 2026-03-27

Target Audience:

This activity was developed for dermatologists, pediatric dermatologists, dermatology nurse practitioners and dermatology physician associates, and other clinicians involved in the management of patients diagnosed with alopecia areata.

This activity is supported by an educational grant from Pfizer Inc.

    Presenting Faculty

  • Brett King, MD, PhD  headshot

    Brett King, MD, PhD

    Associate Professor of Dermatology
    Yale School of Medicine
    New Haven, Connecticut

  • Natasha A. Mesinkovska, MD, PhD  headshot

    Natasha A. Mesinkovska, MD, PhD

    Associate Professor, Dermatology
    UC Irvine School of Medicine
    Irvine, California